These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 2424091)

  • 1. Approaches to the treatment of hepatitis B virus and delta-related liver disease.
    Thomas HC; Lever AM; Scully LJ; Pignatelli M
    Semin Liver Dis; 1986 Feb; 6(1):34-41. PubMed ID: 2424091
    [No Abstract]   [Full Text] [Related]  

  • 2. Alpha 2 recombinant interferon in the treatment of chronic hepatitis delta virus (HDV) hepatitis.
    Rosina F; Saracco G; Lattore V; Quartarone V; Rizzetto M; Verme G; Trinchero P; Sansalvadore F; Smedile A
    Prog Clin Biol Res; 1987; 234():299-303. PubMed ID: 3628384
    [No Abstract]   [Full Text] [Related]  

  • 3. [Interferon treatment of chronic viral hepatitis].
    Pirovino M
    Ther Umsch; 1992 May; 49(5):302-9. PubMed ID: 1377840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural killer cell function during interferon treatment of delta hepatitis.
    Actis GC; Maran E; Saracco G; Rosina F; Baldi M; Brunetto M
    Prog Clin Biol Res; 1987; 234():305-8. PubMed ID: 3628385
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of chronic viral hepatitis.
    de Man RA; Berk L; Schalm SW; Stijnen T
    Dig Dis; 1991; 9(1):17-35. PubMed ID: 1706968
    [No Abstract]   [Full Text] [Related]  

  • 6. Hepatitis B viral infection.
    Thomas HC
    Am J Med; 1988 Aug; 85(2A):135-40. PubMed ID: 3136648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of hepatitis delta virus (HDV) replication by lymphoblastoid human alpha interferon.
    Thomas HC; Farci P; Shein R; Karayiannis P; Smedile A; Caruso L; Gerin J
    Prog Clin Biol Res; 1987; 234():277-90. PubMed ID: 3628382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The interferon therapy of patients with chronic viral hepatitis: the factors affecting the treatment results].
    Kokoreva LN; Zmyzgova AV; Shalygina NB
    Ter Arkh; 1996; 68(2):10-4. PubMed ID: 8771646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of chronic hepatitis B].
    Carreño V; Montaño L; Torres M
    Rev Clin Esp; 1983 Oct; 171(1):73-6. PubMed ID: 6197728
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pathogenesis, therapy, prevention and prognosis in chronic viral hepatitis].
    Pár A
    Orv Hetil; 1992 Jul; 133 Suppl 1():51-63. PubMed ID: 1378584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic viral hepatitis.
    Garcia G; Gentry KR
    Med Clin North Am; 1989 Jul; 73(4):971-83. PubMed ID: 2471027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoglobulin M antibody to hepatitis B core antigen (IgM anti-HBc) as a marker of interferon therapy in patients with persistent hepatitis B virus infection.
    Nakajima E; Tsuji T; Kachi K; Kagawa K; Okanoue T; Takino T; Yamada A; Imanishi J
    Biken J; 1987 Mar; 30(1):17-23. PubMed ID: 3675547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural history and therapy of chronic hepatitis B virus infection.
    Alexander GJ; Williams R
    Am J Med; 1988 Aug; 85(2A):143-6. PubMed ID: 3044078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment with interferon gamma versus interferons alfa and gamma in children with chronic hepatitis B.
    Ruiz-Moreno M; Rúa MJ; Moraleda G; Guardia L; Moreno A; Carreño V
    Pediatrics; 1992 Aug; 90(2 Pt 1):254-8. PubMed ID: 1641292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of hepatitis B surface antigen (HBsAg)-positive chronic hepatitis with recombinant alpha-A-interferon. Results of a phase II study].
    Hess G; Weber C; Rossol S; Voth R; Drees N; Meyer zum Büschenfelde KH
    Z Gastroenterol; 1988 Jul; 26(7):380-7. PubMed ID: 3223006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immunologic staging of chronic active hepatitis B patients in Hawaii.
    Ching N; Lumeng J; Pon E; Ching CY
    Hawaii Med J; 1994 Feb; 53(2):44-5, 49. PubMed ID: 7514583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Interferon therapy in chronic hepatitis B and delta infection in children].
    Nisevich NI; Uchaĭkin VF; Sokolova NV; Kuznetsov VP; Syr'eva TN; Cherednichenko TV; Kaganov BS; Moleva TP; Iusuf-zade AA; Guseva LN
    Vestn Akad Med Nauk SSSR; 1991; (11):56-9. PubMed ID: 1767580
    [No Abstract]   [Full Text] [Related]  

  • 18. [Frequency and clinical relevance of delta virus infection in HBsAg carriers in the Berlin area].
    Möller B; Hopf U; Hoffmann H; Alexander M; Lobeck H
    Z Gastroenterol; 1988 Jun; 26(6):314-21. PubMed ID: 3264646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The hepatitis D virus and its role in the evolution of hepatitis B].
    Antipa C
    Rev Roum Virol; 1992; 43(1-2):87-93. PubMed ID: 1288644
    [No Abstract]   [Full Text] [Related]  

  • 20. [Antiviral treatment of chronic active hepatitis B. Combination therapy with beta interferon and recombinant gamma interferon].
    Eisenburg J; Caselmann W; Eder M; Pape GR
    Fortschr Med; 1988 Jul; 106(21):431-7. PubMed ID: 3146536
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.